Business UpdateNov 10, 2026, 04:36 PM
Elevance Health Reaffirms 2026 Earnings Guidance
AI Summary
Elevance Health, Inc. (ELV) announced that its officers will reaffirm the company's full year 2026 earnings guidance during investor meetings. Shareholders' earnings are expected to be at least $22.00 per diluted share, including approximately $7.00 per diluted share of net unfavorable items. Excluding these items, adjusted shareholders' earnings are projected to be at least $29.00 per diluted share. The company also reaffirmed its full year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
Key Highlights
- Elevance Health reaffirms full year 2026 shareholders' earnings guidance of at least $22.00 per diluted share.
- Excluding net unfavorable items of approximately $7.00 per diluted share, adjusted shareholders' earnings are expected to be at least $29.00 per diluted share.
- Full year 2026 benefit expense ratio guidance is reaffirmed at 90.2% +/- 50 basis points.
Price Impact
More from ELV